Profile
Daniel S.
Grosu is the founder of PetDx, Inc. He previously worked at Sequenom, Inc. as the Chief Medical Officer & Senior Vice President from 2015 to 2016.
Before that, he held the position of Chief Medical Officer & Vice President at Illumina, Inc. Dr. Grosu obtained an MBA from the University of Oxford and a doctorate from Saint Louis University School of Medicine.
Daniel S. Grosu active positions
Companies | Position | Start |
---|---|---|
PetDx, Inc.
PetDx, Inc. BiotechnologyHealth Technology PetDx, Inc. operates as a biotechnology company. It offers cancer detection services. The company is headquartered in San Diego, CA. | Founder | - |
Former positions of Daniel S. Grosu
Companies | Position | End |
---|---|---|
SEQUENOM, INC. | Chief Tech/Sci/R&D Officer | 2016-09-30 |
ILLUMINA, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Daniel S. Grosu
University of Oxford | Masters Business Admin |
Saint Louis University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ILLUMINA, INC. | Health Technology |
Private companies | 2 |
---|---|
Sequenom, Inc.
Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
PetDx, Inc.
PetDx, Inc. BiotechnologyHealth Technology PetDx, Inc. operates as a biotechnology company. It offers cancer detection services. The company is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Daniel S. Grosu